Kazia Therapeutics Launches Groundbreaking Trial of Paxalisib and Immunotherapy for Advanced Breast Cancer
Kazia Therapeutics Limited an oncology-focused drug development company, is pleased to announce the regulatory approval and launch of a clinical trial evaluating the combination of paxalisib and immunotherapy in patients with advanced breast cancer. This …